The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,499
Sort by:
Restenosis (Cardiovascular) - Drugs In Development, 2021
US$ 2,000.00
Restenosis (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restenosis (Cardiovascular) - Drugs In Development,...
June 2021
40 pages
Tyrosine Protein Kinase Mer - Drugs In Development, 2021
US$ 3,500.00
Tyrosine Protein Kinase Mer - Drugs In Development, 2021 SUMMARY According to the recently published report 'Tyrosine Protein Kinase Mer - Drugs In Development, 2021'; Tyrosine Protein Kinase Mer (Pro...
June 2021
94 pages
Investigation Report on China's Anlotinib Market 2021-2025
US$ 2,600.00
Anlotinib is an oral multi-targeting small-molecule tyrosine kinase inhibitor that can target multiple angiogenic factor receptors to inhibit tumor angiogenesis. It can be used for advanced non-small...
June 2021
50 pages
Investigation Report on China's Goserelin Market 2021-2025
US$ 2,600.00
Goserelin is a synthetic analogue of a naturally occurring gonadotropin-releasing hormone (GnRH). Goserelin is developed by AstraZeneca, is mainly used to treat advanced breast and prostate cancer. In...
June 2021
50 pages
Global Erythropoietin Drugs Market Size study, By Drug Class (Biologics, Biosimilars), By Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others), By Application (Cancer, Hematology, Neurology and Renal Diseases) and Regional Forecasts 2021-2027
US$ 3,218.00
Global Erythropoietin Drugs Market is valued approximately USD 11.05 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 11.30% over the forecast period 2021-2027. Eryth...
June 2021
200 pages
Global Vitamin D Therapy Market Size study, by Route of administration (Oral and Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases and Others) and Regional Forecasts 2021-2027
US$ 3,218.00
Global Vitamin D Therapy Market is valued approximately USD 2.11 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 11.3% over the forecast period 2021-2027. Vitamin D...
June 2021
200 pages
Investigation Report on China's Docetaxel Market 2021-2025
US$ 2,600.00
Docetaxel, sold under the brand name Taxotere, is a paclitaxel anti-tumor drug used for the treatment of locally advanced or metastatic non-small cell lung cancer. Docetaxel injection was first develo...
June 2021
50 pages
Investigation Report on China's Omalizumab Market 2021-2025
US$ 2,600.00
Omalizumab, developed by Novartis Europharm, is the only approved antibody designed to target and block immunoglobulin E (IgE). At the end of 2017, the FDA approved the registration of Novartis Europh...
June 2021
50 pages
Investigation Report on China's Pertuzumab Market 2021-2025
US$ 2,600.00
Pertuzumab is the first monoclonal antibody called 'HER dimerization inhibitor'. It mainly used to treat HER2-positive breast cancer. It was developed by Genentech, a subsidiary of Roche Pharma (Schwe...
June 2021
50 pages
Drug Discovery Informatics - Global Market Outlook (2020-2028)
US$ 4,150.00
... Drug Discovery Informatics market. However, Lack of information technology and critical attributes of data evaluation are limiting the market growth. The recent trends in Drug Discovery Informatics are considerable shift observed from traditional in-vitro drug development to computer aided drug designing, as costly failures of late drug development increases ...
June 2021
150 pages
Global Ibuprofen Market, By Product Type (Tablet, Capsule, Syrup and Injection), By Route of Administration (Oral v/s Intravenous), By Application (Rheumatoid Arthritis and Osteoarthritis, Ankylosing Spondylitis, Inflammatory Diseases, Dysmenorrhea, Others), By Age Group (Adult v/s Pediatric), By Source (Contract Manufacturing Organizations (CMO), In-House), By End User (Hospitals, Clinics, Others), By Distribution Channel (Offline v/s Online), By Region, Competition Forecast & Opportunities, 2026
US$ 4,900.00
The global ibuprofen market is expected to grow at a steady rate during the forecast period with a CAGR of 5.67% in value terms to reach USD6945.36 million by 2026. The global ibuprofen market is driv...
June 2021
118 pages
Investigation Report on China's Dasatinib Market 2021-2025
US$ 2,600.00
Dasatinib, developed by Bristol-Myers Squibb, is an anti-tumor drug. It was first approved by the FDA in 2006 for the treatment of adult patients with Philadelphia chromosome-positive (Ph+) chronic my...
May 2021
50 pages
Investigation Report on China's Golimumab Market 2021-2025
US$ 2,600.00
Golimumab is an immunosuppressive medication that can effectively regulate inflammation and bone metabolism. The trade name of Golimumab is SIMPONI, which was developed by Janssen Biologics BV. Its pr...
May 2021
50 pages
Investigation Report on China's Propofol Market 2021-2025
US$ 2,600.00
Propofol is a short-acting intravenous anesthetic. Its uses include the induction and maintenance of general anesthesia, sedation for mechanically ventilated adults, and procedural sedation. It is als...
May 2021
50 pages
